THE IMPACT OF ANTIFUNGALS ON TOLL-LIKE RECEPTORS

THE IMPACT OF ANTIFUNGALS ON TOLL-LIKE RECEPTORS

Fungi are increasingly recognized as major pathogens in immunocompromised individuals. The most common invasive fungal infections are caused by Candida spp., Aspergillus spp. and Cryptococcus spp. Amphotericin B has remained the cornerstone of therapy against many fulminant fungal infections but i...

Full description

Bibliographic Details
Main Authors:	Mircea Radu Mihu, Rodney ePattabhi, Joshua D Nosanchuk
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-03-01
Series:	Frontiers in Microbiology
Subjects:	Amphotericin B Echinocandins Toll-Like Receptors Antifungal Voriconazole caspofungin
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00099/full

Similar Items

The high efficacy of luliconazole against environmental and otomycosis Aspergillus flavus strains
by: Maryam Moslem, et al.
Published: (2020-04-01)

Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran
by: Parisa Badiee, et al.
Published: (2022-12-01)

Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
by: Jia Chen, et al.
Published: (2014-10-01)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01)

Growth and Antifungal Resistance of the Pathogenic Yeast, <i>Candida Albicans</i>, in the Microgravity Environment of the International Space Station: An Aggregate of Multiple Flight Experiences
by: Sheila Nielsen, et al.
Published: (2021-03-01)

Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents
by: Parisa Badiee, et al.
Published: (2022-06-01)

A rare case of scedosporium apiospermum osteomyelitis in an immunocompetent patient
by: Aayushi J. Rajani, et al.
Published: (2024-01-01)

Toll-Like Receptors
by: Aycan Kundakcı, et al.
Published: (2012-08-01)

Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates
by: Prashant Gupta, et al.
Published: (2015-01-01)

Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units
by: Yang Q, et al.
Published: (2022-09-01)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
by: Sepideh Mehravar, et al.
Published: (2024-03-01)

Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-<sc>d</sc>-Glucan Synthase Cause Clinically Important Echinocandin Resistance in <named-content content-type="genus-species">Aspergillus fumigatus</named-content>
by: Shruthi Satish, et al.
Published: (2019-06-01)

In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates
by: Sana Jemel, et al.
Published: (2023-01-01)

Antifungal Drugs
by: Jiří Houšť, et al.
Published: (2020-03-01)

Recent Insights into the Paradoxical Effect of Echinocandins
by: Johannes Wagener, et al.
Published: (2017-12-01)

Role of Antifungal Combinations in Difficult to Treat <i>Candida</i> Infections
by: Roxana G. Vitale
Published: (2021-09-01)

A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
by: Amir Arastefar, et al.
Published: (2016-11-01)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
by: Francis Vekeman, et al.
Published: (2018-08-01)

Pacemaker lead Candida endocarditis: Is medical treatment possible?
by: Syamasis Bandyopadhyay, et al.
Published: (2015-12-01)

Candida and Toll-Like Receptors
by: Şayeste Demirezen, et al.
Published: (2012-12-01)

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
by: Daniela Baracaldo-Santamaría, et al.
Published: (2022-05-01)

Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study
by: P Badiee, et al.
Published: (2011-12-01)

Antifungal Resistance in <i>Candida auris</i>: Molecular Determinants
by: María Guadalupe Frías-De-León, et al.
Published: (2020-09-01)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
by: Gerardo Becerra Victorio, et al.

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
by: Döring Michaela, et al.
Published: (2012-07-01)

The Role of Toll-Like Receptors in Breast Cancer
by: Negin Nokhandani, et al.
Published: (2019-08-01)

Culture media influences Candida parapsilosis growth, susceptibility, and virulence
by: Betsy V. Arévalo-Jaimes, et al.
Published: (2023-12-01)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
by: Noelia Pérez-González, et al.
Published: (2023-04-01)

Identification and characterization of toll-like receptor (TLR) 2 and 4 mutations in colorectal
by: Davoodi, Homa
Published: (2009)

Toll-like receptors and atherosclerosis
by: Jerko Barbić, et al.
Published: (2009-02-01)

Toll-Like Receptors Regulate the Development and Progression of Renal Diseases
by: Minghui Liu, et al.
Published: (2020-12-01)

Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
by: Saahithh Redddi Patlola, et al.
Published: (2023-07-01)

TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Marta Muzio, et al.
Published: (2012-01-01)

The role of Toll-like receptors in skin diseases
by: Joanna Bacharewicz, et al.
Published: (2014-09-01)

Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways
by: Yuan-Tung Chu, et al.
Published: (2023-08-01)

Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
by: Maral Gharaghani, et al.
Published: (2020-06-01)

In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study
by: Niranjan Nayak, et al.
Published: (2013-01-01)

Prognostic role of Toll-like receptors in cancer: a meta-analysis
by: Wang Q, et al.
Published: (2018-07-01)

Polymorphisms of toll-like receptor 2 and 4 genes in Chagas disease
by: German Zafra, et al.
Published: (2008-02-01)

Roles of Toll-Like Receptors in Nitroxidative Stress in Mammals
by: Yao Li, et al.
Published: (2019-06-01)